Liquidia (LQDA) Return on Capital Employed Growth (1y) (2022 - 2026)
Liquidia (LQDA) Return on Capital Employed Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 696.00 |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -494.00 |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 89.00 |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 448.00 |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 1,397.00 |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -1,715.00 |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 999.00 |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -2,309.00 |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 9,717.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,717.00 |
| Dec 31, 2025 | 2,979.00 |
| Sep 30, 2025 | -393.00 |
| Jun 30, 2025 | -2,458.00 |
| Mar 31, 2025 | -753.00 |
| Dec 31, 2024 | 1,539.00 |
| Sep 30, 2024 | -1,041.00 |
| Jun 30, 2024 | -1,490.00 |
| Mar 31, 2024 | -4,102.00 |
| Dec 31, 2023 | -4,434.00 |
| Sep 30, 2023 | -1,717.00 |
| Jun 30, 2023 | -654.00 |
| Mar 31, 2023 | 1,842.00 |
| Dec 31, 2022 | 593.00 |
| Sep 30, 2022 | 626.00 |
| Jun 30, 2022 | 1,326.00 |
| Mar 31, 2022 | 1,622.00 |